Scholarlink

Abstract <p>Assessment tools specifically designed for children are crucial to addressing their unique healthcare needs, enabling more comprehensive and tailored care. This review intends to examine tools that assess multimorbidity in children to uncover critical gaps. This review followed PRISMA guidelines and is registered in PROSPERO (CRD42024520342). This review focused on tools/questionnaires/instruments that assess chronic diseases and multimorbidity among children aged 0–18 years. The search was performed from PubMed, Embase, Web of Science, and CINAHL databases. Eleven studies were included out of 11,876 records screened. The tools (CHQ, ISAAC, DAWBA, and MINI-KID) identified were initially created to assess one condition. They remain widely used in multimorbidity studies because of their validity and common usage, but re-purposing them can restrict full understanding of comorbidities. Other studies used or modified these tools to estimate multimorbidity constructs, with no specifically designed tool employed to estimate childhood multimorbidity. The risk of bias was generally moderate among cross-sectional studies and low among cohort studies. The existing child health questionnaires were not designed for assessing multimorbidity and vary widely in scope and focus. These findings underscore the urgent need for standardized, culturally acceptable, and pediatric-specific tools to assess multimorbidity.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This review highlights critical gaps in pediatric multimorbidity assessment tools, emphasizing their limited scope, validity, and cultural adaptability.</p> </ItemContent> <ItemContent> <p>It analyzes existing methodologies, revealing inconsistencies in chronic condition coverage and a lack of validation across diverse populations.</p> </ItemContent> <ItemContent> <p>The study underscores the need for standardized, comprehensive tools to improve assessment accuracy and management.</p> </ItemContent> <ItemContent> <p>Findings suggest that developing multidimensional instruments will enhance precision and inform better healthcare strategies.</p> </ItemContent> <ItemContent> <p>Addressing these gaps is essential for equitable, evidence-based multimorbidity management in children, ultimately improving long-term health outcomes.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A systematic scoping review and gap analysis of questionnaires to assess multimorbidity among children

  • 期刊论文

  • 发表日期：

    2026年5月8日

查看全文
  • Jogesh Murmu,
  • Abhinav Sinha,
  • Upasana Nayak,
  • Somen Pradhan,
  • Krushna Chandra Sahoo,
  • Debdutta Bhattacharya,
  • Sanghamitra Pati

摘要

Abstract

Assessment tools specifically designed for children are crucial to addressing their unique healthcare needs, enabling more comprehensive and tailored care. This review intends to examine tools that assess multimorbidity in children to uncover critical gaps. This review followed PRISMA guidelines and is registered in PROSPERO (CRD42024520342). This review focused on tools/questionnaires/instruments that assess chronic diseases and multimorbidity among children aged 0–18 years. The search was performed from PubMed, Embase, Web of Science, and CINAHL databases. Eleven studies were included out of 11,876 records screened. The tools (CHQ, ISAAC, DAWBA, and MINI-KID) identified were initially created to assess one condition. They remain widely used in multimorbidity studies because of their validity and common usage, but re-purposing them can restrict full understanding of comorbidities. Other studies used or modified these tools to estimate multimorbidity constructs, with no specifically designed tool employed to estimate childhood multimorbidity. The risk of bias was generally moderate among cross-sectional studies and low among cohort studies. The existing child health questionnaires were not designed for assessing multimorbidity and vary widely in scope and focus. These findings underscore the urgent need for standardized, culturally acceptable, and pediatric-specific tools to assess multimorbidity.

Impact

This review highlights critical gaps in pediatric multimorbidity assessment tools, emphasizing their limited scope, validity, and cultural adaptability.

It analyzes existing methodologies, revealing inconsistencies in chronic condition coverage and a lack of validation across diverse populations.

The study underscores the need for standardized, comprehensive tools to improve assessment accuracy and management.

Findings suggest that developing multidimensional instruments will enhance precision and inform better healthcare strategies.

Addressing these gaps is essential for equitable, evidence-based multimorbidity management in children, ultimately improving long-term health outcomes.